Technical Analysis for SNSE - Sensei Biotherapeutics, Inc.

Grade Last Price % Change Price Change
F 10.2 5.26% 0.51
SNSE closed up 5.26 percent on Thursday, May 13, 2021, on 63 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical SNSE trend table...

Date Alert Name Type % Chg
Slingshot Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 5.26%
New Downtrend Bearish 5.26%
NR7 Range Contraction 5.26%
Lower Bollinger Band Walk Weakness 5.26%
Older End-of-Day Signals for SNSE ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 16 hours ago
Rose Above Previous Day's High about 17 hours ago
Possible Inside Day about 17 hours ago
Possible NR7 about 17 hours ago
60 Minute Opening Range Breakout about 18 hours ago
View Earlier Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Sensei Biotherapeutics, Inc., a clinical-stage immunotherapy company, engages in the discovery and development of therapies with an initial focus on treatments for cancer. The company develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response. It is engineering ImmunoPhage product candidates to directly target antigen presenting cells and modulate the tumor microenvironment through the targeted use of nanobodies which further enhances therapeutic activity. Sensei Biotherapeutics, Inc. was formerly known as Panacea Pharmaceuticals, Inc. The company was founded in 1999 and is headquartered in Rockville, Maryland.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Immunotherapy Cancer Immunotherapy Virotherapy Tumor

Is SNSE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.5
52 Week Low 9.6
Average Volume 116,509
200-Day Moving Average 0.00
50-Day Moving Average 13.83
20-Day Moving Average 12.44
10-Day Moving Average 11.51
Average True Range 0.86
ADX 26.64
+DI 12.95
-DI 32.70
Chandelier Exit (Long, 3 ATRs ) 12.37
Chandelier Exit (Short, 3 ATRs ) 12.17
Upper Bollinger Band 14.99
Lower Bollinger Band 9.89
Percent B (%b) 0.06
BandWidth 40.95
MACD Line -1.10
MACD Signal Line -0.86
MACD Histogram -0.2465
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.21
Resistance 3 (R3) 11.14 10.75 11.04
Resistance 2 (R2) 10.75 10.49 10.78 10.98
Resistance 1 (R1) 10.47 10.33 10.61 10.54 10.93
Pivot Point 10.08 10.08 10.15 10.11 10.08
Support 1 (S1) 9.80 9.82 9.94 9.87 9.47
Support 2 (S2) 9.41 9.66 9.44 9.42
Support 3 (S3) 9.13 9.41 9.36
Support 4 (S4) 9.20